News
The Guselkumab group demonstrated significantly greater clinical and endoscopic responses versus placebo. 2. Serious adverse ...
Among children with acute lymphoblastic leukemia, overweight or obesity at >2 time points (longer duration) was associated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results